ASTE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.761700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.982800E-01
Normal-vs-Stage2
2.886400E-02
Normal-vs-Stage3
1.270020E-01
Normal-vs-Stage4
7.770400E-01
Stage1-vs-Stage2
1.018630E-01
Stage1-vs-Stage3
9.317800E-02
Stage1-vs-Stage4
2.284800E-01
Stage2-vs-Stage3
3.271800E-01
Stage2-vs-Stage4
1.562310E-03
Stage3-vs-Stage4
4.164500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.252200E-02
Normal-vs-AfricanAmerican
4.731600E-01
Normal-vs-Asian
6.597500E-02
Caucasian-vs-AfricanAmerican
2.068400E-01
Caucasian-vs-Asian
4.643600E-01
AfricanAmerican-vs-Asian
1.924000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.572100E-02
Normal-vs-Female
4.032400E-02
Male-vs-Female
6.531200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.817400E-01
Normal-vs-Age(41-60Yrs)
9.513800E-02
Normal-vs-Age(61-80Yrs)
2.802400E-02
Normal-vs-Age(81-100Yrs)
9.035800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.920000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.424000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.797200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.278300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.153400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.270600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.039700E-02
Normal-vs-Daily Drinker
1.567710E-02
Normal-vs-Weekly Drinker
5.262000E-02
Normal-vs-Occasional Drinker
1.395840E-01
Normal-vs-Social Drinker
3.880600E-01
Non Drinker-vs-Daily Drinker
7.676000E-01
Non Drinker-vs-Weekly Drinker
7.109000E-01
Non Drinker-vs-Occasional Drinker
1.859200E-01
Non Drinker-vs-Social Drinker
9.214200E-02
Daily Drinker-vs-Weekly Drinker
5.391200E-01
Daily Drinker-vs-Occasional Drinker
1.313620E-01
Daily Drinker-vs-Social Drinker
5.096400E-02
Weekly Drinker-vs-Occasional Drinker
4.284400E-01
Weekly Drinker-vs-Social Drinker
2.349800E-01
Occasional Drinker-vs-Social Drinker
8.146000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.196000E-01
Normal-vs-Grade 2
3.144400E-02
Normal-vs-Grade 3
5.724500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.802300E-02
Grade 1-vs-Grade 3
1.377240E-01
Grade 1-vs-Grade 4
2.196000E-01
Grade 2-vs-Grade 3
8.987800E-01
Grade 2-vs-Grade 4
3.144400E-02
Grade 3-vs-Grade 4
5.724500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.270400E-02
Normal-vs-NonDiabetic
1.474210E-02
Diabetic-vs-NonDiabetic
3.841600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.464600E-01
Normal-vs-NoPancreatitis
2.150000E-02
Pancreatitis-vs-NoPancreatitis
4.765200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.510300E-02
Normal-vs-N1
3.186200E-02
N0-vs-N1
8.569800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.137990E-01
Normal-vs-TP53-NonMutant
1.731770E-01
TP53-Mutant-vs-TP53-NonMutant
9.558400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
